{"id":23144,"date":"2023-03-07T10:00:18","date_gmt":"2023-03-07T09:00:18","guid":{"rendered":"https:\/\/idibell.cat\/?p=23144"},"modified":"2023-03-07T11:55:25","modified_gmt":"2023-03-07T10:55:25","slug":"la-braquiterapia-en-tumors-inicials-de-cancer-de-mama-es-mes-rapida-i-amb-menys-efectes-secundaris-que-la-radioterapia-convencional","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2023\/03\/la-braquiterapia-en-tumors-inicials-de-cancer-de-mama-es-mes-rapida-i-amb-menys-efectes-secundaris-que-la-radioterapia-convencional\/","title":{"rendered":"La braquiter\u00e0pia en tumors inicials de c\u00e0ncer de mama \u00e9s m\u00e9s r\u00e0pida i amb menys efectes secundaris que la radioter\u00e0pia convencional"},"content":{"rendered":"<p>La braquiter\u00e0pia en les pacients amb tumors inicials de c\u00e0ncer de mama, i despr\u00e9s de realitzar una cirurgia conservadora, \u00e9s m\u00e9s r\u00e0pida i t\u00e9 menys efectes secundaris per a les pacients. Aquesta \u00e9s la principal conclusi\u00f3 d\u2019un estudi internacional publicat a la revista cient\u00edfica \u2018<a href=\"https:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(23)00018-9\/fulltext\">The Lancet Oncology<\/a>\u2019 en el que hi han participat 16 hospitals d\u2019arreu del continent europeu i que ha comptat amb la col\u00b7laboraci\u00f3 de l\u2019Institut Catal\u00e0 d\u2019Oncologia (ICO), l\u2019Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) i l\u2019Institut Valenci\u00e0 d\u2019Oncologia (IVO).<\/p>\n<p>En aquest estudi s\u2019han analitzat 1.328 pacients amb un tumor inicial de c\u00e0ncer de mama que, despr\u00e9s d\u2019una cirurgia conservadora de mama, han estat tractades aleat\u00f2riament el 50% amb irradiaci\u00f3 complerta de tota la mama (radioter\u00e0pia convencional) i l\u2019altra meitat amb braquiter\u00e0pia amb tubs pl\u00e0stics, irradiant nom\u00e9s el llit quir\u00fargic (al voltant d&#8217;on estava el tumor). Despr\u00e9s d\u2019un seguiment de 10 anys, s\u2019han complert els objectius inicials de l\u2019estudi: demostrar que es pot mantenir el control local i minimitzar aix\u00ed els efectes secundaris.<\/p>\n<h3>\nTractaments m\u00e9s senzills i amb menys efectes secundaris<\/h3>\n<p>&nbsp;<\/p>\n<p>La principal conclusi\u00f3 \u00e9s que el tractament amb braquiter\u00e0pia durant nom\u00e9s 4-5 dies \u00e9s m\u00e9s r\u00e0pid davant les 30 sessions que es realitzen amb la radioter\u00e0pia externa i que duren 6 setmanes . Aix\u00f2 ja \u00e9s un benefici per a la pacient per\u00f2 no \u00e9s l\u2019\u00fanic ja que la braquiter\u00e0pia t\u00e9 menys efectes secundaris en la pell, la resta del teixit de la mama no es veu afectat i el pulm\u00f3 i el cor reben menys irradiaci\u00f3. Aquest fet minimitza les mol\u00e8sties per a les pacients i reverteix en el seu benestar, reduint el risc de complicacions a llarg termini.<\/p>\n<p>Per a la cap cl\u00ednic de la Unitat de Braquiter\u00e0pia de l\u2019ICO a l\u2019Hospitalet i investigadora de l\u2019IDIBELL, <strong>Cristina Gutierrez<\/strong>, <em>\u201caquest estudi \u00e9s important perqu\u00e8 es demostra que tant la radioter\u00e0pia externa com la <\/em><em>braquiter\u00e0pia<\/em><em> s\u00f3n segures i eficaces, ja que ambd\u00f3s tractaments s\u00f3n equivalents a nivell de control local, per\u00f2, a m\u00e9s, les pacients tractades amb <\/em><em>braquiter\u00e0pia<\/em><em> tenen menys efectes secundaris\u201d<\/em> i afegeix \u201c<em>aquest estudi contribueix a donar a con\u00e8ixer la <\/em><em>braquiter\u00e0pia<\/em><em> en c\u00e0ncer de mama\u201d<\/em>.<\/p>\n<p>Per la seva banda el cap del Servei d\u2019Oncologia Radioter\u00e0pica de l\u2019IVO, <strong>Jos\u00e9 Luis Guinot<\/strong>, destaca que \u201c<em>aquest \u00e9s el primer estudi a nivell mundial que ha demostrat que la irradiaci\u00f3 parcial de la mama (en lloc de radiar la mama sencera) \u00e9s el tractament d\u2019elecci\u00f3 per a pacients operades amb tumors de baix risc. Amb deu anys de seguiment es confirmen els resultats inicials, consolidant aquest canvi d&#8217;enfocament que beneficia milers de pacients amb el tipus de c\u00e0ncer m\u00e9s freq\u00fcent en dones<\/em>\u201d.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>L\u2019Institut d&#8217;Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l&#8217;Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l&#8217;Institut Catal\u00e0 de la Salut, l&#8217;Institut Catal\u00e0 d&#8217;Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n<p><em>L\u2019IDIBELL \u00e9s membre del Campus d&#8217;Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L&#8217;any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aix\u00ed ho demostren els resultats d\u2019un estudi internacional que ha comptat amb la participaci\u00f3 de l\u2019Institut Catal\u00e0 d\u2019Oncologia (ICO), l\u2019Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) i l\u2019Institut Valenci\u00e0 d\u2019Oncologia (IVO) i en el que es fa una comparativa entre les dues t\u00e8cniques.   <\/p>\n","protected":false},"author":8,"featured_media":23145,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[332,447,372],"tags":[],"class_list":["post-23144","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","category-p-de-mecanismes-molelculars-i-terapia-experimental-en-oncologia-oncobell","category-radiobiologia-i-cancer"],"publishpress_future_action":{"enabled":false,"date":"2024-12-25 17:48:14","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/23144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=23144"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/23144\/revisions"}],"predecessor-version":[{"id":23146,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/23144\/revisions\/23146"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/23145"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=23144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=23144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=23144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}